Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness
2021 · Molecular Therapy · 85 citations
https://doi.org/10.1016/j.ymthe.2021.02.016
H
Hui Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
257
Papers
2.7K
Citations
28
h-index
73
i10-index
Hui Li is an academic researcher from Shihezi University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 28, co-authored 219 publications.
ORCID: 0000-0001-7145-4681Papers by this author
worksMicroRNA-29b Regulates Ethanol-induced Neuronal Apoptosis in the Developing Cerebellum through SP1/RAX/PKR Cascade
2014 · Journal of Biological Chemistry · 68 citations
https://doi.org/10.1074/jbc.m113.535195
LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer
2021 · Cell Death and Disease · 43 citations
https://doi.org/10.1038/s41419-020-03188-0
The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis
2017 · Scientific Reports · 35 citations
https://doi.org/10.1038/s41598-017-10001-0
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer
2013 · mAbs · 32 citations
https://doi.org/10.4161/mabs.27443
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
2022 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-022-05510-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat